Personalized pain research intelligence
PainSignal is a free, personalized research-intelligence platform for people living with pain, their families, and caregivers. It tracks new studies, clinical trials, medications, devices, treatment approaches, approvals, and care guidance, then turns the developments that matter to you into clear, trustworthy explanations.
Always free for patients, families, and caregivers. Educational information only—never a diagnosis or treatment recommendation.
Researchers are studying whether an investigational approach may help adults with peripheral neuropathic pain.
Fictional example showing the planned portal experience—not a live research or trial update.
The first signal
Join the early-access list for a focused first look at PainSignal. We'll send only meaningful product and launch updates—not a stream of generic health content.
Why PainSignal
Pain research moves quickly, but the people most affected by it are often left to find, interpret, and judge each development on their own.
New findings live across medical journals, trial registries, regulatory announcements, conference presentations, and company updates. Most are written for researchers or clinicians, and early findings can be easy to overstate.
PainSignal continuously monitors the research and treatment landscape, filters it for personal relevance, and explains what changed, why it may matter, how strong the evidence is, what remains uncertain, and what to ask a care team.
Inside your portal
Search when you want to explore. Save what matters. Let PainSignal bring important developments to you when you do not have time or energy to keep checking.
Plain-language updates ranked by the conditions, symptoms, treatments, and questions you choose to follow.
Return to past explanations, source papers, treatment developments, and saved updates.
Follow medications, devices, procedures, and other approaches from early research toward clinical use.
Explore studies using high-level details such as condition, age range, location, travel, and time commitment.
Follow approvals, new indications, clinical guidance, and care developments relevant to your interests.
Manage followed topics, saved studies, bookmarked questions, reading history, and notification preferences.
Create concise pages to bring to an appointment or share with a family member or care team.
How PainSignal works
A simple path from the questions you care about to a clear, source-linked explanation.
Follow conditions, symptoms, medications, treatments, researchers, locations, and topics, then choose how much detail you want.
The platform tracks research papers, trial activity, treatment pipelines, regulatory decisions, conference findings, and clinical guidance.
Each update explains what changed, why it may matter, how strong the evidence is, what remains uncertain, and where a treatment sits in development.
Use the portal, email digest, immediate alerts, or optional texts, then inspect sources, save updates, and prepare questions for your care team.
Evidence approach
Each signal shows how far the evidence has traveled—and what could still change the picture. Maturity is context, not a treatment recommendation.
Designed around peer-reviewed journals, official trial registries, health agencies, regulatory updates, and clinical guidance.
Laboratory, animal, or exploratory work. Interesting, but far from established care.
Studied in people. Safety, benefit, and who it may apply to can still be uncertain.
Multiple human studies point in a similar direction, with quality and results still compared.
Evidence has informed professional guidance or a regulatory decision. Personal fit still varies.
Personal by design
Choose conditions, symptoms, treatments, locations, and research questions. Use a quick patient-and-family explanation or open a deeper version when you want more detail.
Topic choices do not create or confirm a diagnosis. Location and age filters are high-level preferences, not eligibility checks.
Trial alerts, responsibly framed
Possible matches use condition, age range, location, and other high-level criteria. PainSignal can make study stage, major requirements, travel, time commitment, and next steps easier to inspect.
This is not clinical screening or an endorsement. Only the study team can confirm eligibility, and registry details can change between updates.
Registry criteria are not a clinical screening. Verify the official record, confirm details with the study team, and discuss participation with a qualified health professional.
How PainSignal is sustained
Research and clinical organizations pay for responsible communication, study outreach, patient-engagement tools, and professional research intelligence.
Organizations can fund tools for translating and distributing approved study information and supporting patient engagement.
Sponsors and research sites can support clearly identified, condition-specific awareness and referral programs.
Foundations, advocacy groups, health systems, and life-sciences organizations may sponsor labeled educational series or condition channels.
Research teams may use paid dashboards, trend monitoring, communication tools, and privacy-protected aggregate insights.
The funding firewall
Trust depends on keeping commercial relationships separate from evidence, explanations, and relevance. Partnerships can expand access, but they never confer editorial control.
Read the brand and trust guidePainSignal does not diagnose, prescribe, or replace medical care. Trial suggestions are possible matches, not confirmation of eligibility.
For research and clinical organizations
PainSignal can support universities, hospitals, trial sites, nonprofits, CROs, biotechnology companies, and pharmaceutical companies with research translation, compliant study awareness, patient-engagement tools, and privacy-protected intelligence.
Initial product
The first version will serve a small number of high-need pain conditions with three core ways to understand, follow, and act on relevant developments.
This site is an illustrative product preview. Patient accounts, profiles, and alerts are not yet available here.
Questions, answered plainly
The product is still taking shape. These are the promises and boundaries that will not be blurred.
Yes. Patients, families, and caregivers never pay to use the portal, receive alerts, read research explanations, or explore trial information. There are no premium patient tiers.
Revenue comes from research and clinical organizations that pay for communication, study outreach, engagement, and professional intelligence tools. Payment does not influence independent explanations or relevance ranking.
No. Sponsors cannot edit explanations, suppress findings, or pay for favorable ranking. Sponsored material is visibly labeled and kept separate from editorial decisions.
No. PainSignal will not sell identifiable patient data. Professional products may use privacy-protected aggregate insights that do not identify individual users.
AI may help monitor sources, organize developments, and create structured first drafts. Published explanations must pass a defined quality-review process and clearly show uncertainty, limitations, and evidence maturity.
No. A suggestion is a lead based on broad interests and preferences, not a clinical eligibility review. Only the study team can determine eligibility, and criteria or recruiting status may change.
No. PainSignal explains research for educational purposes. It does not diagnose, prescribe, recommend treatment, interpret medical records, or replace a qualified health professional.
This page is an illustrative product preview. Join the early-access list to hear when the first focused release is ready. Privacy, source, and review systems are being established before broader access.